Skip to content

Propionyl-Fructooligosaccharide Alleviates DSS-Induced Colitis in Association with Changes in Gut Microbiota, Inflammatory Responses, and Intestinal Barrier Function

Oct 2026 · Journal of Agricultural and Food Chemistry · 0 citations · 39 references

Abstract

Propionyl-fructooligosaccharide (P-FOS), an esterified prebiotic synthesized from fructooligosaccharides and propionic acid, was evaluated in a dextran sulfate sodium (DSS)-induced colitis mouse model. P-FOS treatment was associated with lower disease activity, attenuated colon shortening, reduced histological injury, and the preservation of goblet cells. P-FOS also decreased the expression of several inflammation-associated markers and increased barrier-related gene and protein expression, including Muc2 mRNA and occludin protein. In addition, P-FOS treatment was associated with changes in gut microbial diversity and composition and with altered colonic short-chain fatty acid profiles. Because gastrointestinal stability, ester bond cleavage, and direct propionate release from P-FOS were not determined, these findings should not be interpreted as direct evidence of a colon-targeted release mechanism. Overall, P-FOS showed protective effects in DSS-induced colitis and warrants further investigation as an esterified prebiotic.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.